Evidence map›Paper›PMID 29685906›Full record

ArticleMolecular and cellular biology2018

The VCP-UBXN1 Complex Mediates Triage of Ubiquitylated Cytosolic Proteins Bound to the BAG6 Complex.

Rakesh Ganji, Sirisha Mukkavalli, Flavio Somanji, Malavika Raman

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. A second chance for protein targeting/folding: Ubiquitination and deubiquitination of nascent proteins.BioEssays : news and reviews in molecular, cellular and developmental biology · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rakesh GanjiDepartment of Developmental Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Sirisha MukkavalliDepartment of Developmental Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Flavio SomanjiDepartment of Developmental Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Malavika RamanDepartment of Developmental Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA malavika.raman@tufts.edu.ORCID 0000-0002-4773-8673
Tufts University · US

Funding

“Regulation of Protein Quality Control by the VCP AAA-ATPase”R01GM127557 · NIGMS · TUFTS UNIVERSITY BOSTON · PI Malavika Raman · 2018 to 2026
$3.5M
The Role Of p97-Chaperone Complexes In Protein Quality ControlK22CA175142 · NCI · TUFTS UNIVERSITY BOSTON · PI RAMAN, MALAVIKA · 2015 to 2017
$540k
NCI NIH HHS K22 CA175142NIGMS NIH HHS R01 GM127557
6 · The paper itself

Abstract

A balance between protein synthesis and degradation is necessary to maintain cellular homeostasis. Failure to triage aberrant proteins may result in their accumulation and aggregation in the cytosol. The valosin-containing protein (VCP)-BCL2-associated athanogene 6 (BAG6) complex facilitates a wide variety of ubiquitin-mediated quality control events at the endoplasmic reticulum (ER), both prior to ER translocation and during ER-associated degradation (ERAD). However, how ubiquitylated clients associated with BAG6 are recognized by VCP for proteasomal degradation is presently unknown. We have identified UBXN1 as the VCP adaptor in BAG6-dependent processes occurring prior to ER insertion but not during ERAD. The loss of VCP-UBXN1 results in the inappropriate stabilization of ubiquitylated BAG6 clients and their accumulation in insoluble aggregates and sensitizes cells to proteotoxic stress. Our results identify how VCP is specifically targeted to ubiquitylated substrates in the BAG6 triage pathway and suggest that the degradation of ubiquitylated clients by the proteasome is reliant on the association of UBXN1 with ubiquitylated substrates and the catalytic activity of VCP.

Indexed as

Adaptor Proteins, Signal TransducingCytosolEndoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationHEK293 CellsHeLa CellsHumansModels, BiologicalMolecular ChaperonesMultiprotein ComplexesProteasome Endopeptidase ComplexProtein BindingProteostasisUbiquitinationValosin Containing ProteinAdaptor Proteins, Signal TransducingBAG6 protein, humanMolecular ChaperonesMultiprotein ComplexesProteasome Endopeptidase ComplexUBXN1 protein, humanValosin Containing ProteinVCP protein, humanproteasomeprotein quality controlubiquitinVCP

Identifiers

PMID29685906
PMCPMC6002697
OpenAlexW2799669851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.